Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$27.52 USD
-2.69 (-8.90%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $27.81 +0.29 (1.05%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Fundamental Charts
About Return on Equity (TTM)
Twist Bioscience Corporation's return on equity, or ROE, is -29.38% compared to the ROE of the Medical - Biomedical and Genetics industry of -62.42%. While this shows that TWST has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
TWST 27.52 -2.69(-8.90%)
Will TWST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TWST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TWST
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
TWST: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?
Other News for TWST
Q3 2025 Twist Bioscience Corp Earnings Call Transcript
ARK Investment Makes Significant Purchase of Twist Bioscience (TWST)
Cathie Wood's ARK Investment buys 154.3K shares of Twist Bioscience today
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Twist Bioscience price target lowered by $22 at TD Cowen, here's why